Stock report · Delisted · Nasdaq
Mural Oncology plc (MURA)
2.04USD Delisted Final close · Dec 3, 2025
MURA no longer trades. Mural Oncology was delisted from the Nasdaq in December 2025.
All prices on this page are historical. The last trade was on December 3, 2025, at $2.04.
MURA stock price history
Final trading statistics
- Final close
- $2.04
- Final trading day
- Dec 3, 2025
- Market cap at delisting
- $35.38M
- Shares outstanding
- 17.34M
- Final 52-week range
- $0.95 – $4.74
- Avg. volume (final 3 mo.)
- 171,610
- All-time high
- $6.01 · Dec 2023
- All-time low
- $1.00 · Apr 2025
- Return since IPO
- -46.3%
- Beta
- 2.96
- Book value / share
- $3.19
- Price / book
- 0.64
About Mural Oncology plc
Mural Oncology plc was a clinical-stage cancer company working on immunotherapies. Its lead candidate, nemvaleukin alfa, was being studied alone for mucosal melanoma and together with pembrolizumab for platinum-resistant ovarian cancer.
It was also testing nemvaleukin in cutaneous melanoma and advanced solid tumors, and it had programs for engineered interleukin-18 and tumor-targeted interleukin-12. Incorporated in 2017 and based in Dublin, Ireland, it became a subsidiary of XOMA Royalty Corporation as of December 4, 2025.
The shares were delisted from the Nasdaq in December 2025, with the last trade on December 3, 2025 at $2.04.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Dublin
- Employees
- 116
- IPO date
- November 16, 2023
- Delisted
- December 3, 2025
- SEC CIK
- 1971543
Mural Oncology financials before the delisting
The last 4 fiscal years Mural Oncology reported as a public company, fiscal year ending December.
MURA revenue and net income
MURA earnings per share
MURA annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | −$128.5M | −$7.58 |
| FY2023 | $0.00 | −$207.4M | −$3.57 |
| FY2022 | $0.00 | −$189.8M | — |
| FY2021 | $0.00 | −$175.4M | — |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Mural Oncology stock FAQ
What happened to Mural Oncology stock?
Mural Oncology was delisted from the Nasdaq in December 2025. The final close was $2.04 on December 3, 2025.
Can I still buy MURA stock?
No. MURA is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on December 3, 2025.
What was the last price of MURA?
MURA last closed at $2.04 on December 3, 2025, which valued the company at about $35.38M.
How did Mural Oncology do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Mural Oncology reported revenue of $0.00 and net income of −$128.5M.
When did Mural Oncology go public?
Mural Oncology shares started trading on November 16, 2023.
MURA no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.